Table 2 CGM monitored blood profiles in study subjects.
From: Features of glycemic variations in drug naïve type 2 diabetic patients with different HbA1c values
Items | L Group | M Group | H Group |
|---|---|---|---|
24-hrs MG (mmol/L) | 9.46 ± 1.85 | 11.47 ± 2.19a** | 13.52 ± 2.20ab** |
SDMG (mmol/L) | 2.00 ± 0.79 | 2.55 ± 0.90a** | 2.88 ± 0.99a**b* |
MAGE (mmol/L) | 5.20 ± 2.35 | 6.30 ± 2.38a* | 7.44 ± 3.00a**b* |
AUC (<3.9 mmol/L*Day) | 0.01 ± 0.07 | 0.00 ± 0.01 | 0.00 ± 0.03 |
AUC (>10.0 mmol/L*Day) | 0.80 ± 0.93 | 2.18 ± 1.57a** | 3.76 ± 1.90ab** |
PG (mmol/L) | 13.23 ± 3.49 | 16.27 ± 3.62a** | 18.63 ± 2.98 a**b** |
Time to peak (min) | 91.36 ± 31.01 | 82.94 ± 26.54 | 108.00 ± 30.19ab* |